Post by BioThrust

In CGT, many moonshots are less of a distant vision and more of a manufacturing challenge. In the end, it all boils down to producing high quality therapeutic material at large scale and in a cost-efficient process. That is exactly what our bioreactors are designed for - optimize upstream and the mission is no longer impossible.